Daws D. Ryan
Insider CIK 1598602 · CNCE Chief Financial Officer · ENGN Chief Financial Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ENGN enGene Holdings Inc. | A Award deriv | 2026-01-30 | 2026-02-03 | 220,000 | — | $0 | 220,000 | SEC↗ |
| ENGN enGene Holdings Inc. | A Award deriv | 2025-01-29 | 2025-01-31 | 280,000 | — | $0 | 280,000 | SEC↗ |
| ENGN enGene Holdings Inc. | A Award deriv | 2023-11-30 | 2023-12-04 | 232,000 | — | $0 | 232,000 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | A Award deriv | 2017-01-04 | 2017-01-06 | 82,500 | — | $0 | 82,500 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | A Award deriv | 2016-01-07 | 2016-01-08 | 50,000 | — | $0 | 50,000 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | A Award deriv | 2014-06-10 | 2014-06-12 | 50,000 | — | $0 | 50,000 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | A Award deriv | 2014-02-19 | 2014-02-19 | 123,893 | — | $0 | 123,893 | SEC↗ |